Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy analysis of 6-substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester derivatives. (2024). International Journal of Pharmaceutical Sciences and Drug Research, 16(3), 378-386. https://doi.org/10.25004/IJPSDR.2024.160309